Acetyl tetrapeptide-9
Specifications
928006-50-2CAS Number
618-875-8EC Number
(3S)-3-[[(2S)-2-acetamido-5-amino-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acidIUPAC Name
C22H33N7O9Chemical Formula
539.5 g/molMolecular Weight
Acetyl tetrapeptide-9; 928006-50-2; Dermican; UNII-VMO8OOD3V0; N-Acetyl-gln-asp-val-his; VMO8OOD3V0; LS 9745; LS-9745; DTXSID00239151; L-Histidine, N2-acetyl-L-glutaminyl-L-alpha-Aspartyl-L-valyl-; RefChem:109073; DTXCID20161642; ACETYL TETRAPEPTIDE-9 [INCI]; L-HISTIDINE, N2-ACETYL-L-GLUTAMINYL-L-.ALPHA.-ASPARTYL-L-VALYL-; 618-875-8; Acetyl tetrapeptide-9(Dermican LS 9837); Acetyltetrapeptide-9(DermicanLS9837); (2S,5S,8S,11S)-2-((1H-imidazol-4-yl)methyl)-11-(3-amino-3-oxopropyl)-8-(carboxymethyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanoic acid; Acetyl Tetrapeptide-9 (acetate); (3S)-3-[[(2S)-2-acetamido-5-amino-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid; (3S)-3-[(2S)-4-carbamoyl-2-acetamidobutanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propanoic acid; MFCD30830312; Acetyl tetrapeptide-9?; orb1983729; Acetyl Tetrapeptide-9 (Powder); SCHEMBL21529460; SCHEMBL31187019; Acetyl Tetrapeptide-9 (Liquid); QNZANUZIBYJBIN-XSWJXKHESA-N; C22H33N7O9; (2S,5S,8S,11S)-2-((1H-Imidazol-4-yl)methyl)-11-(3-amino-3-oxopropyl)-8-(carboxymethyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic acid; DMB00650; HY-P3164; TP2365; AKOS030573453; BP-41207; DA-50137; DS-19817; CS-0166887; C77180; Q27291905; N~2~-Acetyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidine; (3S)-3-[[(2S)-2-acetamido-5-amino-5-oxo-pentanoyl]amino]-4-[[(1S)-1-[[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]carbamoyl]-2-methyl-propyl]amino]-4-oxo-butanoic acidSynonyms